Publications, Lectures & Book Chapters

  1. Caires, R., Luis, E., Taberner, FJ., Fernandez-Ballester, G., Ferrer-Montiel, A., Balazs, EA., Gomis, A., Belmonte. C. and de la Peña, E. (2015). Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain. Nature Communications, 6(8095):1-11.

  2. Band PA, Heeter J, Wisniewski H-G, Liublinska V, Pattanayak CW, Karia RJ, Stabler T, Balazs EA and Kraus VB. Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression. Osteoarthritis and Cartilage. 2015;23(1):70-76.

  3. Balazs EA. and Cui J. (2013). The story of hyaluronan putty. Bioactive Carbohydrates and Dietary Fibre, 2(2):143-151.

  4. Darzynkiewicz, Z. and Balazs, EA. (2012). Genome integrity, stem cells and hyaluronan. Aging, 4(2):78-88.

  5. Balazs, EA (2011). The Early History of Hyaluronan Research. In History of Hyaluronan Science-Hyaluronan: From Basic Science to Clinical Applications (Balazs, EA., Hargittai, I. and Hargittai, M., eds.), PubMatrix, Edgewater, NJ (USA), Volume 2:1-70.

  6. Balazs, EA. (2011). Karl Meyer's Contributions to Hyaluronan Sciences. In History of Hyaluronan Science-Hyaluronan: From Basic Science to Clinical Applications (Balazs, EA., Hargittai, I. and Hargittai, M., eds.), PubMatrix, Edgewater, NJ (USA), Volume 2:71-111.

  7. Balazs, EA., Mitlitski, I. and Heeter, J. (2010). In vitro cell behavior on hyaluronan fluids and gels. In 8th International Conference on Hyaluronan, Kyoto, Japan, June 6-11, 2010, Kyoto, Japan.

  8. Wilcox-Adelman, SA., Mitlitski, I., Roulet, M. and Balazs, EA. (2010). Cell adhesion to hyaluronan gel promotes motility via activation of the transcriptional factor twist. In 8th International Conference on Hyaluronan, Kyoto, Japan, June 6-11, 2010, Kyoto, Japan.

  9. Balazs, EA., Gibbs, DA. and Heeter, J. (2010). Analysis of the polydispersity of hyaluronan. In 8th International Conference on Hyaluronan, Kyoto, Japan, June 6-11, 2010, Kyoto, Japan.

  10. Band, PA., Denlinger, JL. and Balazs, EA. (2010). Hyaluronan as a therapeutic agent. Poster presented at American Chemical Society (ACS) 239th National Meeting, March 21-25, 2010, San Francisco, CA (USA).

  11. Luan, T., Andres, M., Fang, Y., Al-Assaf, S., Phillips, GO., Zhang, H. and Balazs, EA. (2010). Molecular characterization of hyaluronan from bacterial and animal sources. In 8th International Conference on Hyaluronan, Kyoto, Japan, June 6-11, 2010, Kyoto, Japan.

  12. Halicka, HD., Mitlitski, V., Heeter, J., Balazs, EA. and Darzynkiewicz, Z. (2009). Attenuation of the oxidative burst-induced DNA damage in human leukocytes by hyaluronan. International J Molecular Med, 23(5):695-699.

  13. Armand, G. and Balazs, EA. (2009). Ichthyosan in fish eye. Struct Chem, 20:337-340.

  14. Balazs, EA. (2009). Therapeutic use of hyaluronan. Struct Chem 20:341-349.

  15. Balazs, EA. (2009). The role of hyaluronan in the structure and function of the biomatrix of connective tissues. Struct Chem 20:233-243.

  16. Balazs, EA. (2009). Introductory remarks. Struct Chem 20:229-232.

  17. Hascall, V. and Balazs, EA. (2009). Karl Meyer - 1890--1990. A Biographical Memoir by Vincent C. Hascall and Endre A. Balazs, Washington, D.C. (US). Biographical Memoirs. National Academy of Sciences, Washington, D.C. (US), 1-15.

  18. Zhao, H., Tanaka, T., Mitlitski, V., Heeter, J., Balazs, EA. and Darzynkiewicz, Z. (2008). Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int J Oncol 32:1159-1167.

  19. Balazs, EA. (2008). Hyaluronan as an ophthalmic viscoelastic device. Current Pharmaceutical Biotechnology 9(4):236-238.

  20. Balazs, EA. and Band, PA. (2008). Therapeutic use of hyaluronan-based products. In Carbohydrate Chemistry, Biology and Medical Applications (Eds. Garg, HG., Cowman, M. K. and Hales, CA.), Elsevier, Ltd., Amsterdam (The Netherlands):311-332.

  21. Spagnoli, C., Korniakov, A., Ulman, A., Balazs, EA., Lyubchenko, Y L. and Cowman, MK. (2005). Hyaluronan conformations on surfaces: effect of surface charge and hydrophobicity. Carbohydr Res 340:929-941.

  22. Cowman, MK., Spagnoli, C., Kudasheva, D., Li, M., Dyal, A., Kanai, S. and Balazs, EA. (2005). Extended, relaxed, and condensed conformations of hyaluronan observed by atomic force microscopy. Biophys J. 88:590-602.

  23. Balazs, E.A., Eliezer, I. K., Denlinger, BL., Mitlitski, V. and Whetstone, JL. (2005). Cell assembly on hyaluronan and hylan matrices. In Hyaluronan: Structure, Metabolism, Biological Activities, Therapeutic Applications (Eds. Balazs, EA. and Hascall, VC.), Matrix Biology Institute, Edgewater, NJ (USA) Volume II:797-802.

  24. Cowman, MK., Spagnoli, C., Kudasheva, DS., Matsuoka, S. and Balazs, EA. (2005). Influence of environment on hyaluronan shape. In Hyaluronan: Structure, Metabolism, Biological Activities, Therapeutic Applications (Eds. Balazs, EA. and Hascall, VC.), Matrix Biology Institute, Edgewater, NJ (USA) Volume I:79-87.

  25. Band, PA., Eliezer, IK., Mitlitski, V. and Balazs, EA. (2005). Hyaluronan uptake and intracellular localization using different binding protocols. In Hyaluronan: Structure, Metabolism, Biological Activities, Therapeutic Applications (Eds. Balazs, EA. and Hascall, VC.), Matrix Biology Institute, Edgewater, NJ (USA) Volume II:619-624.

  26. Gomis, A., De la Peña, E., Balazs, EA., Schmidt, RF. and Belmonte, C. (2005). Hyaluronan derivatives and joint pain. In Hyaluronan: Structure, Metabolism, Biological Activities, Therapeutic Applications (Eds. Balazs, E A. and Hascall, VC), Matrix Biology Institute, Edgewater, NJ (USA), Volume II:503-507.

  27. Gomis, A., Pawlak, M., Balazs, EA., Schmidt, RF. and Belmonte, C. (2004). Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthr. Rheum 50:314-326.

  28. Balazs, EA. (2004). Viscoelastic properties of hyaluronan and its therapeutic use. In Chemistry and Biology of Hyaluronan (Eds. Garg, HG. and Hales, CA.), Elsevier Ltd., Amsterdam:415-455.

  29. Balazs, EA (2004). Viscosupplementation for treatment of osteoarthritis: From initial discovery to current status and results. Surgical Technology International (12):278-289.

  30. Balazs, EA (2003). Analgesic effect of elastoviscous HA solutions and the treatment of arthritic pain. Cells Tissues Organs 174(1-2):49-62.

  31. Haider, A., Grabarek, J., Eng, J., Pedraza, P., Ferreri, N., Balazs, EA. and Darzynkiewicz, Z. (2003). In vitro model of "wound healing" analyzed by laser scanning cytometry: Accelerated healing of epithelial cell monolayers in the presence of hyaluronate. Cytometry, 53A:1-8.

  32. Balazs, EA. (2003). Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells, Tissues, Organs 174:49-62.

  33. Armand, G., Fan, K. and Balazs, EA. (2002). The heat dependence of hyaluronan conformation. In Hyaluronan Chemical, Biochemical and Biological Aspects (Eds. Kennedy, J. F., Phillips, GO., Williams, PA. and Hascall, VC.), Woodhead, Cambridge, UK, Volume I:99-102.

  34. Balazs, EA., Larsen, NE., Leshchiner, EA., Boney, JD, Mitlitski, V., Parent, EG. and Whetstone, JL. (2002). Dry film made of hylan to prevent adhesion between two healing tissue surfaces. In Hyaluronan Biomedical, Medical and Clinical Aspects (Eds. Kennedy, JF., Phillips, GO., Williams, PA. and Hascall, V. C.), Woodhead, Cambridge, UK, Volume 2:7-12.

  35. Balazs, EA., Eliezer, IK., Dennebaum, RA., Larsen, NE. and Whetstone, JL. (2002). Cell attachment and growth on solid hyaluronan (hylan B gel). In Hyaluronan Biomedical, Medical and Clinical Aspects (Eds. Kennedy, JF., Phillips, GO., Williams, PA., and Hascall, VC.), Woodhead, Cambridge, UK, Volume 2:33-38.

  36. Balazs, EA. and Weiss, C. (2002). Elastoviscous hyaluronan in the synovium in health and disease. In The Many Faces of Osteoarthritis (Eds. Hascall, VC. and Kuettner, KE.), Birkhäuser, Basel, Switzerland:189-206.

  37. Hoefling, JM., Cowman, MK., Matsuoka, S. and Balazs, EA. (2002). Temperature effect on the dynamic rheological characteristics of hyaluronan, hylan A and Synvisc. In Hyaluronan Biomedical, Medical and Clinical Aspects (Eds. Kennedy, JF., Phillips, GO., Williams, PA. and Hascall, VC.), Woodhead, Cambridge, UK, Volume 1:103-108.

  38. Hoefling, JM., Matsuoka, S. and Balazs, EA. (2002). Rheological creep experiments utilizing mixtures of 1% hylan A solution and 0.5% hylan B gel slurry. In Hyaluronan Chemical, Biochemical and Biological Aspects (Eds. Kennedy, JF., Phillips, GO., Williams, PA. and Hascall, VC.), Woodhead, Cambridge, UK, Volume 1:195-200.

  39. Armand, G., Fan, K. and Balazs, EA. (2002). The heat dependence of hyaluronan conformation. In Hyaluronan Biomedical, Medical and Clinical Aspects (Eds. Kennedy, JF., Phillips, GO., Williams, PA. and Hascall, VC.), Woodhead, Cambridge, UK, Volume 1:99-102.

  40. Balazs, EA. (2000). Why hyaluronan has so many biological activities. In New Frontiers in Medical Sciences: Redefining Hyaluronan (Proceedings of the Symposium held in Padua, Italy, 17-19 June 1999) (Eds. Abatangelo, G. and Weigel, P.), Elsevier, Amsterdam:3-10.

  41. Cowman, MK., Li, M., Dyal, A. and Balazs, EA. (2000). Tapping mode atomic force microscopy of the hyaluronan derivative, hylan A. Carbohydrate Polymers 41:229-235.